We advised the underwriters on the offering

Davis Polk advised the underwriters in connection with an SEC-registered offering by Inventiva S.A. of 44,805,193 American depositary shares (ADSs), representing 44,805,193 of its ordinary shares, which included the full exercise of the underwriters’ option to purchase additional ADSs. Inventiva’s ADSs are listed on the Nasdaq Global Market under the symbol “IVA,” and its ordinary shares are listed on Euronext Paris under the same symbol.

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis, or MASH.

The Davis Polk capital markets team included partners Deanna L. Kirkpatrick and Yasin Keshvargar and associates Kerim K. Aksoy, Xuanling Xu and Madison White. Partner David R. Bauer and associates Francesca Masella and Elizabeth Pott provided intellectual property advice. The tax team included counsel Dustin Plotnick and associate Omar Hersi. All members of the Davis Polk team are based in the New York office.

Copy link to share post